glp-1 contraindications thyroid The Twist: How Agonists Are Influencing Autoimmune Thyroid Care Glucagon-like Peptide-1 Receptor Agonists and

Harris)

Patients were randomly assigned to groups that received retatrutide or a placebo

Key safety signals observed in the Phase 2 trial included gastrointestinal adverse effects (nausea, vomiting, diarrhoea, and constipation), increases in resting heart rate, and gallbladder-related events consistent with the broader class of incretin-based therapies

The utilization of the FAERS in pharmacovigilance is indispensable, yet its application is constrained by several notable limitations

Ask your provider about which GLP-1 medication they recommend and why

Nevertheless, it is associated with increased incidence of gastrointestinal adverse reactions [17]